Cholesterol, lipoproteins, and cognitive impairment

Area of Science:

• Neuroscience
• Cardiovascular Science
• Gerontology

Background:

• Amyloid beta deposition is central to Alzheimer disease (AD) pathogenesis.
• Animal studies suggest cholesterol influences amyloid beta deposition.
• Cardiovascular disease risk factors are linked to AD and vascular disease.

Purpose of the Study:

• To discuss the role of cholesterol in Alzheimer disease pathogenesis.
• To review the impact of mid-life cholesterol and cardiovascular risk factors on AD.
• To examine potential interventions including statin therapy and lifestyle modifications.

Main Methods:

• Literature review of studies on amyloid beta deposition, cholesterol, and AD.
• Analysis of animal data supporting cholesterol's role in amyloidogenesis.
• Examination of clinical observations linking cardiovascular risk factors to AD and vascular disease.

Main Results:

• Cholesterol plays a significant role in amyloid beta deposition, a key factor in AD.
• Mid-life cholesterol levels and cardiovascular risk factors are associated with AD and vascular disease.
• Statin therapy's efficacy in large-scale AD trials remains unproven, though research is ongoing.

Conclusions:

• While lifestyle interventions like diet and exercise are valuable, no definitive drugs currently exist to prevent or treat AD.
• Further research is crucial to develop safe and effective treatments for Alzheimer disease.
• Understanding the interplay between cholesterol, cardiovascular health, and AD is essential for future therapeutic strategies.